Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT02254018 · COMPLETED
Trial details
- NCT number
- NCT02254018
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2005-02-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.